https://share.google/pKPhuLUxIOuNaGSff
Answer Summary
Members shared excitement about a remyelination therapy trial aimed at restoring lost function in multiple sclerosis, with many expressing... Read more
With any new drug, I usually will wait until it has been released and used for a couple of years. Call me paranoid, however I don’t trust the FÐA especially after the c0vid debacle.
I left a message with my Ms dr's assistant yesterday, asking about being involved in this trial 🙏🏼
There are a couple going on the newest being PTD802. The FDA cleared the investigational new drug application in June 2026 allowing clinical trials to begin. It's a selective GPR17 antagonist. In MS GPR17 expression gets dysregulated which stops OPC's from maturing into myelin-producing cells. PTD802 blocks this receptor to remove the blockade and promote remyelination. I'm cautiously optimistic
That's super exciting. I would totally try it. I was recently approved to go to the multiple schlorosis center of excellence in okc. I'm definitely going to ask about it or anything that actually repairs myelin rather than just slows progression. I'm game to be a lab rat for whatever could help me and others.
I got a referral to a nuerology center too. Thank you Jesus 🙏
https://omrf.org/patients/multiple-sclerosis-ce...
https://neurologycare.com/?gad_source=1&gad...
It’s in phase two- safety and ethics, I am going to wait until it has fda clearance